Health Care · Health Care Equipment
Abbott Laboratories: revenue, profit and dividends
In fiscal 2025, Abbott Laboratories had revenue of $44.3B, up 8.1% a year on average since 2015, and net income of $6.52B (14.7% of revenue). Its dividend per share has gone up 3 years in a row, to $2.40. It has 16% more shares than in 2015.
Revenue, fiscal 2025
average annual revenue growth since 2015 · +5.7% vs 2024
- Ticker
- ABT · NYSE
- Sector
- Health Care
- Sub-industry
- Health Care Equipment
- Headquarters
- North Chicago, Illinois
- Founded
- 1888
- In the S&P 500 since
- March 4, 1957, the index’s first day
- Latest fiscal year
- 2025, ended December 31, 2025
- SEC filer
- Abbott Laboratories · CIK 0000001800
Revenue and net income
Revenue went from $25.9B in 2007 to $44.3B in 2025.
Diluted earnings per share
Diluted EPS went from $2.31 in 2007 to $3.72 in 2025. Ten-year growth: 2.5% a year.
Dividends per share
Raised 3 years in a row, every year from 2023 to 2025.
Shares outstanding
16.1% more shares in 2025 than in 2015 (1.51B → 1.75B): new shares outweighed buybacks.
Operating cash flow, capex and free cash flow
Free cash flow (operating cash flow minus capital expenditure) was $7.39B in 2025, 16.7% of revenue.
The chart data could not be loaded. The table below has the same figures.
Year by year
| Fiscal year | Revenue | Net income | Net margin | Diluted EPS | Dividend | Shares | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $44.3B | $6.52B | 14.7% | $3.72 | $2.40 | 1.75B | $9.57B | $2.17B | $7.39B |
| 2024 | $42B | $13.4B | 31.9% | $7.64 | $2.24 | 1.75B | $8.56B | $2.21B | $6.35B |
| 2023 | $40.1B | $5.72B | 14.3% | $3.26 | $2.08 | 1.75B | $7.26B | $2.2B | $5.06B |
| 2022 | $43.7B | $6.93B | 15.9% | $3.91 | $1.92 | 1.76B | $9.58B | $1.78B | $7.8B |
| 2021 | $43.1B | $7.07B | 16.4% | $3.94 | — | 1.79B | $10.5B | $1.89B | $8.65B |
| 2020 | $34.6B | $4.5B | 13.0% | $2.50 | — | 1.79B | $7.9B | $2.18B | $5.72B |
| 2019 | $31.9B | $3.69B | 11.6% | $2.06 | — | 1.78B | $6.14B | $1.64B | $4.5B |
| 2018 | $30.6B | $2.37B | 7.7% | $1.33 | — | 1.77B | $6.3B | $1.39B | $4.91B |
| 2017 | $27.4B | $477M | 1.7% | $0.27 | — | 1.75B | $5.57B | $1.14B | $4.43B |
| 2016 | $20.9B | $1.4B | 6.7% | $0.94 | — | 1.48B | $3.2B | $1.12B | $2.08B |
| 2015 | $20.4B | $4.42B | 21.7% | $2.92 | — | 1.51B | $2.97B | $1.11B | $1.86B |
| 2014 | $20.2B | $2.28B | 11.3% | $1.49 | — | 1.53B | $3.67B | $1.08B | $2.6B |
| 2013 | $19.7B | $2.58B | 13.1% | $1.62 | — | 1.57B | $3.32B | $1.15B | $2.18B |
| 2012 | $19.1B | $5.96B | 31.3% | $3.72 | — | 1.59B | $9.31B | $1.79B | $7.52B |
| 2011 | $21.4B | $4.73B | 22.1% | $3.01 | $1.92 | 1.57B | $8.97B | $1.49B | $7.48B |
| 2010 | $35.2B | $4.63B | 13.2% | $2.96 | $1.76 | 1.56B | $8.74B | $1.02B | $7.72B |
| 2009 | $30.8B | $5.75B | 18.7% | $3.69 | $1.60 | 1.56B | $7.28B | $1.09B | $6.19B |
| 2008 | $29.5B | $4.88B | 16.5% | $3.12 | — | 1.56B | $6.99B | $1.29B | $5.71B |
| 2007 | $25.9B | $3.61B | 13.9% | $2.31 | — | 1.56B | $5.18B | $1.66B | $3.53B |
Fiscal years, labelled by the year in which they end. US dollars; per-share figures and share counts adjusted for splits. —: not in the data.
About these figures
- Older years are as filed at the time and may predate later restatements, mergers or spin-offs. How the figures are made.
Other Health Care Equipment companies
Source: SEC EDGAR (company filings), data as of November 8, 2026. Sectors, sub-industries, headquarters and index dates: Wikipedia, CC BY-SA 4.0.